A Phase I/II Study of CLOLAR (Clofarabine, IND 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia.

Trial Profile

A Phase I/II Study of CLOLAR (Clofarabine, IND 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Clofarabine (Primary) ; Cytarabine; Methotrexate
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 30 Sep 2015 Study design has been changed from single group assignment to parallel group assignment as reported by ClinicalTrials.gov record.
    • 22 Oct 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top